A long-term clinical trial found that structured exercise after colon cancer treatment improved survival outcomes and reduced recurrence rates, offering evidence to support physical activity as part of survivorship care.
Tevimbra added to chemo before esophageal cancer surgery doubled complete response rates in a phase 2 trial, hinting at a future shift in standard care.